Introduction

This page provides a comprehensive analysis of the known insider trading history of Rajiv Shukla. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Rajiv Shukla has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:CTCX / Carmell Corporation Chairman and CEO, Director, 10% Owner 72,103
US:HUMA / Humacyte, Inc. Director 13,000
US:CNACU / Constellation Alpha Capital Corp. Unit CEO & Chairman, Director, 10% Owner 3,882,500
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Rajiv Shukla. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by Rajiv Shukla as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2024-06-10 2024-06-06 4 CTCX Carmell Corp
Common Stock
P - Purchase 2,100 72,103 3.00 2.63 5,527 189,753
2024-06-10 2024-05-30 4 CTCX Carmell Corp
Common Stock
P - Purchase 2,000 70,003 2.94 2.50 5,000 175,008
2024-06-10 2024-05-28 4 CTCX Carmell Corp
Common Stock
P - Purchase 20 68,003 0.03 2.57 51 174,768
2024-06-10 2021-07-26 4 CTCX Carmell Corp
Common Stock
J - Other 0 4,249,908 0.00
2024-05-28 2024-05-24 4 CTCX Carmell Corp
Common Stock
P - Purchase 1,939 67,983 2.94 2.57 4,991 174,988
2024-05-28 2024-05-23 4 CTCX Carmell Corp
Common Stock
P - Purchase 2,100 66,044 3.28 2.50 5,250 165,110
2024-05-28 2021-07-26 4 CTCX Carmell Corp
Common Stock
J - Other 0 4,249,908 0.00
2024-05-22 2024-04-04 4 CTCX Carmell Corp
Common Stock
P - Purchase 8,680 57,206 17.89 2.88 24,998 164,753
2024-05-22 2021-07-26 4 CTCX Carmell Corp
Common Stock
J - Other 0 4,249,908 0.00
2024-05-22 2024-05-22 4 CTCX Carmell Corp
Common Stock
P - Purchase 4,051 63,944 6.76 2.41 9,771 154,233
2024-05-22 2024-05-21 4 CTCX Carmell Corp
Common Stock
P - Purchase 1,515 59,893 2.60 2.39 3,616 142,965
2024-05-22 2024-05-20 4 CTCX Carmell Corp
Common Stock
P - Purchase 1,172 58,378 2.05 2.22 2,601 129,541
2024-05-22 2021-07-26 4 CTCX Carmell Corp
Common Stock
J - Other 0 4,249,908 0.00
2024-01-04 2023-01-02 4 CTCX Carmell Corp
Common Stock
A - Award 14,347 48,526 41.98
2024-01-04 2021-07-26 4 CTCX Carmell Corp
Common Stock
J - Other 0 4,249,908 0.00
2023-12-04 2023-12-01 4 CTCX Carmell Corp
Common Stock
P - Purchase 502 34,179 1.49 2.50 1,255 85,448
2023-12-04 2023-11-30 4 CTCX Carmell Corp
Common Stock
P - Purchase 5,600 33,677 19.95 2.66 14,917 89,705
2023-12-04 2023-11-29 4 CTCX Carmell Corp
Common Stock
P - Purchase 5,014 28,077 21.74 2.91 14,578 81,634
2023-12-04 2023-11-28 4 CTCX Carmell Corp
Common Stock
P - Purchase 2,501 23,063 12.16 2.92 7,303 67,346
2023-12-04 2021-07-26 4 CTCX Carmell Corp
Common Stock
J - Other 0 4,249,908 0.00
2023-11-28 2023-11-27 4 CTCX Carmell Corp
Common Stock
P - Purchase 2,100 20,562 11.37 2.97 6,247 61,170
2023-11-28 2023-11-24 4 CTCX Carmell Corp
Common Stock
P - Purchase 2,715 18,462 17.24 2.95 7,999 54,393
2023-11-28 2023-11-22 4 CTCX Carmell Corp
Common Stock
P - Purchase 1,185 15,747 8.14 2.78 3,291 43,733
2023-11-28 2021-07-26 4 CTCX Carmell Corp
Common Stock
J - Other 0 4,249,908 0.00
2023-11-21 2023-11-21 4 CTCX Carmell Corp
Common Stock
P - Purchase 200 14,562 1.39 2.49 497 36,197
2023-11-21 2023-11-20 4 CTCX Carmell Corp
Common Stock
P - Purchase 3,750 14,362 35.34 2.62 9,817 37,598
2023-11-21 2023-11-17 4 CTCX Carmell Corp
Common Stock
P - Purchase 2,000 10,612 23.22 2.69 5,380 28,545
2023-11-21 2021-07-26 4 CTCX Carmell Corp
Common Stock
J - Other 0 4,249,908 0.00
2023-08-31 2023-08-28 4 CTCX Carmell Corp
Common Stock
P - Purchase 2,100 8,612 32.25 3.50 7,343 30,114
2023-08-31 2023-08-25 4 CTCX Carmell Corp
Common Stock
P - Purchase 600 6,512 10.15 3.50 2,100 22,792
2023-08-31 2023-08-24 4 CTCX Carmell Corp
Common Stock
P - Purchase 500 5,912 9.24 3.50 1,750 20,692
2023-08-31 2023-08-21 4 CTCX Carmell Corp
Common Stock
P - Purchase 100 5,412 1.88 3.54 354 19,158
2023-08-31 2023-08-18 4 CTCX Carmell Corp
Common Stock
P - Purchase 4,100 5,312 338.28 3.62 14,825 19,208
2023-08-31 2023-08-17 4 CTCX Carmell Corp
Common Stock
P - Purchase 100 1,212 8.99 3.54 354 4,290
2023-08-31 2023-08-16 4 CTCX Carmell Corp
Common Stock
P - Purchase 1,112 1,112 3.74 4,154 4,154
2021-10-15 2021-10-13 4 HUMA Humacyte, Inc.
Stock Options (right to buy)
A - Award 13,000 13,000
2020-09-23 2020-09-22 4 AHACU Alpha Healthcare Acquisition Corp.
Class A Common Stock
J - Other 305,000 305,000 10.00 3,050,000 3,050,000
2017-06-26 2017-06-23 4 CNACU Constellation Alpha Capital Corp.
Ordinary Shares
J - Other -136,250 3,882,500 -3.39
2017-06-26 2017-06-23 4 CNACU Constellation Alpha Capital Corp.
Ordinary Shares
P - Purchase 425,000 4,018,750 11.83 10.00 4,250,000 40,187,500
2017-06-19 3 CNACU Constellation Alpha Capital Corp.
Ordinary Shares
7,187,500
2017-06-19 3 CNACU Constellation Alpha Capital Corp.
Ordinary Shares
7,187,500
2017-06-19 3 CNACU Constellation Alpha Capital Corp.
Ordinary Shares
7,187,500
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)